Letter regarding article by Weintraub et al, "Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure".
Stecker
Eric C
EC
McAnulty
John H
JH
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D000077545:Eplerenone; D017048:Health Care Costs; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D010919:Placebos; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use*; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000188:drug therapy* / Q000191:economics
D010919:Placebos; D013148:Spironolactone; D000077545:Eplerenone